November 7, 2024 10:53 AM EST
News Briefing

Geron’s roy­al­ty deal; Minghui’s new VEGF bis­pe­cif­ic da­ta

ENDPOINTS

Plus, news about ADC Ther­a­peu­tics, Celldex and Virac­ta Ther­a­peu­tics:

Geron inks up to $375M roy­al­ty and debt deal: The com­pa­ny now

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

No­var­tis seeks more bolt-on deals as it pur­chas­es neu­ro start­up for up to $1.1B

RFK Jr. and Elon Musk want to ban phar­ma ads. They would­n't be the first to try

Am­gen names Stan­ford ge­neti­cist and biotech founder to CSO post

FDA vac­cine chief Pe­ter Marks pledges to stay as long as he's wel­come

Ky­owa Kirin ac­quires ex-US rights to Ku­ra’s leukemia treat­ment for $330M up­front

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times